Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Nipah virus persists in the brains of nonhuman primate survivors.

Liu J, Coffin KM, Johnston SC, Babka AM, Bell TM, Long SY, Honko AN, Kuhn JH, Zeng X.

JCI Insight. 2019 Jul 25;4(14). pii: 129629. doi: 10.1172/jci.insight.129629. eCollection 2019 Jul 25.

2.

Long-term neurological and functional outcome in Nipah virus infection.

Sejvar JJ, Hossain J, Saha SK, Gurley ES, Banu S, Hamadani JD, Faiz MA, Siddiqui FM, Mohammad QD, Mollah AH, Uddin R, Alam R, Rahman R, Tan CT, Bellini W, Rota P, Breiman RF, Luby SP.

Ann Neurol. 2007 Sep;62(3):235-42.

PMID:
17696217
3.

Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.

Satterfield BA, Cross RW, Fenton KA, Borisevich V, Agans KN, Deer DJ, Graber J, Basler CF, Geisbert TW, Mire CE.

J Virol. 2016 Jun 24;90(14):6326-6343. doi: 10.1128/JVI.00215-16. Print 2016 Jul 15.

4.

Contribution of Human Lung Parenchyma and Leukocyte Influx to Oxidative Stress and Immune System-Mediated Pathology following Nipah Virus Infection.

Escaffre O, Saito TB, Juelich TL, Ikegami T, Smith JK, Perez DD, Atkins C, Levine CB, Huante MB, Nusbaum RJ, Endsley JJ, Freiberg AN, Rockx B.

J Virol. 2017 Jul 12;91(15). pii: e00275-17. doi: 10.1128/JVI.00275-17. Print 2017 Aug 1.

5.

Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.

Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC.

PLoS One. 2010 May 18;5(5):e10690. doi: 10.1371/journal.pone.0010690.

6.

Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.

Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC.

Sci Transl Med. 2014 Jun 25;6(242):242ra82. doi: 10.1126/scitranslmed.3008929.

7.

Lethal Nipah virus infection induces rapid overexpression of CXCL10.

Mathieu C, Guillaume V, Sabine A, Ong KC, Wong KT, Legras-Lachuer C, Horvat B.

PLoS One. 2012;7(2):e32157. doi: 10.1371/journal.pone.0032157. Epub 2012 Feb 29.

8.

Henipavirus infection of the central nervous system.

Dawes BE, Freiberg AN.

Pathog Dis. 2019 Mar 1;77(2). pii: ftz023. doi: 10.1093/femspd/ftz023.

PMID:
30985897
9.

Subclinical infection without encephalitis in mice following intranasal exposure to Nipah virus-Malaysia and Nipah virus-Bangladesh.

Dups J, Middleton D, Long F, Arkinstall R, Marsh GA, Wang LF.

Virol J. 2014 Jun 2;11:102. doi: 10.1186/1743-422X-11-102.

10.

Hendra virus and Nipah virus animal vaccines.

Broder CC, Weir DL, Reid PA.

Vaccine. 2016 Jun 24;34(30):3525-34. doi: 10.1016/j.vaccine.2016.03.075. Epub 2016 May 4.

11.

[Nipah virus infections].

Kitsutani P, Ohta M.

Nihon Rinsho. 2005 Dec;63(12):2143-53. Review. Japanese.

PMID:
16363687
12.

Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.

Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang L, Wang YE, Vigant F, Gao J, Wu P, Lee B, Freiberg AN.

J Virol. 2015 Jan 15;89(2):1242-53. doi: 10.1128/JVI.02583-14. Epub 2014 Nov 12.

13.

A human lung xenograft mouse model of Nipah virus infection.

Valbuena G, Halliday H, Borisevich V, Goez Y, Rockx B.

PLoS Pathog. 2014 Apr 3;10(4):e1004063. doi: 10.1371/journal.ppat.1004063. eCollection 2014 Apr.

14.

Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.

Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H.

J Virol. 2011 Aug;85(15):7658-71. doi: 10.1128/JVI.00473-11. Epub 2011 May 18.

15.

Pathogenicity of Nipah henipavirus Bangladesh in a swine host.

Kasloff SB, Leung A, Pickering BS, Smith G, Moffat E, Collignon B, Embury-Hyatt C, Kobasa D, Weingartl HM.

Sci Rep. 2019 Mar 26;9(1):5230. doi: 10.1038/s41598-019-40476-y.

16.

Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.

Singh RK, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, Munjal A, Vora KS, Latheef SK, Karthik K, Singh Malik Y, Singh R, Chaicumpa W, Mourya DT.

Vet Q. 2019 Dec;39(1):26-55. Review.

PMID:
31006350
17.

Emerging trends of Nipah virus: A review.

Sharma V, Kaushik S, Kumar R, Yadav JP, Kaushik S.

Rev Med Virol. 2019 Jan;29(1):e2010. doi: 10.1002/rmv.2010. Epub 2018 Sep 24. Review.

PMID:
30251294
18.

Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering.

Liu Q, Bradel-Tretheway B, Monreal AI, Saludes JP, Lu X, Nicola AV, Aguilar HC.

J Virol. 2015 Feb;89(3):1838-50. doi: 10.1128/JVI.02277-14. Epub 2014 Nov 26.

19.

Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.

Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, Wolf MC, Holbrook MR, Freiberg AN, Lee B.

PLoS Pathog. 2010 Nov 11;6(11):e1001186. doi: 10.1371/journal.ppat.1001186.

20.

Establishment of an RNA polymerase II-driven reverse genetics system for Nipah virus strains from Malaysia and Bangladesh.

Griffin BD, Leung A, Chan M, Warner BM, Ranadheera C, Tierney K, Audet J, Frost KL, Safronetz D, Embury-Hyatt C, Booth SA, Kobasa D.

Sci Rep. 2019 Aug 1;9(1):11171. doi: 10.1038/s41598-019-47549-y.

Supplemental Content

Support Center